Click here to find the details of your local office.
mlcoa is a truly national provider with over 100 locations across Australia. We deliver services across all metropolitan areas, and numerous regional and remote communities, plus we have a dedicated international team who deliver independent assessments for individuals residing overseas.
By: REARDON, S., Nature NEWS Sara Reardon is a freelance science journalist from Bozeman, Montana with a role as a staff reporter at high-profile scientific journals including Nature, New Scientist and Science. The findings in a nutshell Long COVID
Uniquely associate with kynurenine pathway activation: a longitudinal observation study By: CYSIQUE L., JAKABEK D., BRACKEN S.G., et al. Preprint from medRxiv; DOI: 10.1101/2022.06.07.22276020 The authors are all Australian medical experts and researchers based in NSW at institutions including St
By: ANTONELLI M., PUJOL J.C., SPECTOR T.D., OURSELINE S. & STEVES C.J. The Lancet: Correspondence Work supported by the UK department of Health; Research team based at Kings College, London, UK. The findings in a nutshell Omicron appears to cause
Aged 18-64 and 65+ years By: BULL-OTTERSON L., BACA S., SAYDAH S., et al. MMWR Morb Mortal Wkly Rep, 71:713-37 The authors are affiliated with the Center for Disease Control, United States Department of Health and Human Services. The
COVID-19 PROTOCOLS With the ongoing COVID-19 situation across Australia, mlcoa would like to reassure our customers, that the safety of our clients, staff, and consultants remain paramount. As a business dealing in healthcare, mlcoa have protocols in place to mitigate
By: UK HEALTH SECURITY AGENCY (UKHSA) The findings in a nutshell Published in late January 2022, this report presents data on COVID-19 cases, hospitalisations and deaths by vaccination status in the UK. The ‘vaccine effectiveness’ section of the report
By: WISE, J. BRITISH MEDICAL JOURNAL, 376:O309 The findings in a nutshell The UK’s regulator approved Novavax’s COVID-19 vaccine, following it’s approval by the European Medicines Agency in December 2021. This vaccine has also recently been approved for use in